ABL-mediated SOS1 phosphorylation promotes RAC activation, contributing to leukemogenic effects driven by BCR–ABL, thereby underscoring the noteworthy role of SOS1 in CML progression (32, 58). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.